In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

20:36 EST 26th November 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,100+

Monday 24th November 2014

The Ebola Report: 2014 Epidemic And R&D Drug Prospects

LONDON, November 24, 2014 /PRNewswire/ -- Report Details   The Ebola Report - new study showing you trends and R&D progress What opportunities are there in a market for Ebola diagnostics, prevention, and treatment? What are the commercial prospects for this market and related technologies? Visiongain's new report shows market potential for products and other trends, discussing data, opp...

SQI DIAGNOSTICS Advances Commercial Opportunity with Leading Global Pharmaceutical Customer

TORONTO, Nov. 24, 2014 /PRNewswire/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD) (OTCQX: SQIDF) today announced that it has expanded its existing commercial relationship with one of the world's largest pharmaceutical companies. This final step in commercializing the Company's Ig_plex™ platform could lead to significant on-going revenue opportunities as the ...

Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress

ENGLEWOOD, Colo., Nov. 24, 2014 /PRNewswire/ -- Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), today announced the presentation of three clinical and preclinical studies showcasing its RedoxSYS™ Diagnostic System as a broadly applicable and robust research tool capable of measuring oxidation-reduction potential (ORP) in the body in response to injury,...

Government review aims to speed up NHS access to new medicines

The government has launched another review into how to accelerate access to new drugs, devices, and diagnostics. George Freeman, minister for life sciences, said, “By revolutionising the way in which...

FDAnews Announces Choosing the Best Device Sample Size for Verification and Validation: Tools to Safely Speed Your Device to Market, On-Demand Webinar, Dec. 15, 2014

Device manufacturers understand that they must answer the two key design verification and validation questions: did they make the product right and did they make the right product? Learn proven tactics and tools to develop a strong statistical methods program — and a thorough understanding of what FDA auditors look for when they come for an inspection. Falls Church, VA (PRWEB) November 24, 2014 ...

Horizon Discovery gains exclusive access to new diagnostics platform

Horizon Discovery has negotiated an exclusive licensing and  distribution agreement with Adarza BioSystems, the developer of a new early stage disease diagnostics tool.

Global Pregnancy Detection Card Market 2015-2019

Recently added to the BioPortfolio report store, Global Pregnancy Detection Card Market 2015-2019 is a new report from Technavio published on 2014-11-18. This 71-page report is available in pdf from $2500. About Pregnancy Detection Card Pregnancy detection cards are diagnostic products that check for chemical markers related to pregnancy. The card or cassette format is one of the three categorie...

Sunday 23rd November 2014

Collaboration in research commercialisation

The University of Technology, Sydney (UTS) and the Kolling Institute of Medical Research have launched SPARK Sydney - a start-up program to aid the commercialisation of health and medical research. Said to be the first of its kind in Australia, the program will work through the education and mentoring of research staff and the successful advancement of translational research in medical and health ...

DOCTO: New App to Revolutionize Fitness and Medical Wearables

Vancouver, Canada, November 23, 2014 --(PR.com)-- There are a lot of Apps designed to target the health-conscious fitness market each claiming to be better than the next, but DOCTO has them all beat. Most wearable devices, whether they log medical or fitness data, are nothing more than a standard tracking system with a digital journal attached to them. DOCTO takes things one step further by analy...

Friday 21st November 2014

Bruce H. Levin Has Recently Been Recognized by America’s Registry of Outstanding Professionals

Farmingdale, NY, November 22, 2014 --(PR.com)-- Dr. Bruce H. Levin is currently associated with the Pennsylvania Spine and Headache Center in Philadelphia, Pennsylvania. www.interventionalpainmanagement.com His M.D. was earned at the Albert Einstein College of Medicine. Dr. Levin’s main area of practice lies in interventional pain medication and medical devices. Through many years of innova...

Pharmaceutical Research: Formulation and Pharmacokinetics of Thermosensitive Stealth® Liposomes Encapsulating 5-Fluorouracil

Type: Original PaperPurposeWe optimize the encapsulation and investigate the pharmacokinetics of 5-Fluorouracil (5-FU) delivered by thermosensitive stealth® liposomes (TSLs) designed to trigger drug release upon hyperthermia using focused ultrasound...

FDA workshop on therapies for rare patient subsets

FDA will hold a public workshop on Dec. 12 to discuss approaches to evaluate precision therapies targeting subsets of patients with rare molecular characteristics. The Center for Translational and Regulatory Sciences at the University of Virginia wi...

Genetic Signatures seeks to go public in Australia

Molecular diagnostics firm Genetic Signatures Ltd. filed for its initial public offering on the Australian Stock Exchange.

After Embryo Checks for Genetic Defects, Twin Joy for Chennai Woman

(Times of India) – In a unique technique that could boost the success of in-vitro fertilization (IVF) procedures, a fertility centre in the city helped Divya deliver a pair of twins after testing the embryo for genetic defects before implanting...

Yabao Pharmaceuticals and MRC Technology Announces Exclusive China Partnership

BEIJING and LONDON, Nov. 21, 2014 (GLOBE NEWSWIRE) -- Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351), a leading pharmaceutical company in China, today announced an exclusive license with MRC Technology, a medical research charity, to discover, develop and commercialise innovative products targeting a kinase target for neurodegeneration for the treatment of Parkinson&ap...

Anti-Migraine Drugs Market Research Reports And Industry Analysis 2014-19

Anti-Migraine Drugs Market Research Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. Albany, NY (PRWEB) November 21, 2014 In the coming years, the market for anti-migraine drugs is anticipated to witness several launches of new generic migraine drugs that will steadily increase the drug-treatment levels and rate of diag...

European Metropolitan Area of Munich Is Top Location for Biotechnology and Pharmaceutical Industries

New study by the Chamber of Industry and Commerce (IHK), the City of Munich and BioM confirms the importance of this sector Munich, Germany, November 21, 2014 / B3C newswire / - The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue and staff numbers despite ever-increasing international competition. This continues Munich's status as one of the pre-em...

LabCorp Completes Acquisition of LIPOSCIENCE

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the completion of its acquisition of LIPOSCIENCE, Inc. (NASDAQ:LPDX), effective November 20, 2014. At a special meeting held on November 20, 2014, LIPOSCIENCE’s stockholders approved the acquisition and the transaction closed promptly thereafter. After the close ...

CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales

ORLANDO, Fla., Nov. 21, 2014 /PRNewswire/ -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on April 4, 2014 reported nine months and the 3rd quarter sales ended September 30, 2014 of $8.7 million and $2.8 million. Operating income was $448,000 for the nine months ended September 2014 and a $38,000 loss for the quarter ended September 2014. "Even though our 3rd quarter is usually a seasonab...

Collagen Solutions To Acquire Leading NZ Based Providers of Medical Grade Collagen for £6 Million

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, today announced the proposed acquisition of New Zealand based Southern Lights Biomaterials) for a total maximum consideration of NZ$12m (c. £6m) in cash and shares. The acquisiti...

Verastem Presents Data at the 2014 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Results from the Phase 1 Dose Escalation Study of VS-6063 in Japanese Patients and New Preclinical Results Support Continued Clinical Development of VS-6063 and VS-5584 in Mesothelioma and Other Cancers Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced...

UK aims to shave years off drug development

The UK government has announced an 'end to end' review of how drugs are developed, approved and accessed by patients in a bid to make the country a leader in biomedical innovation.The new Innovative Medicines and MedTech Review has been announced by ...

U.K. launches Innovative Medicines Review

The U.K. government is launching an Innovative Medicines Review, which will consider how to speed up patient access to cost-effective and innovative medicines, devices and diagnostics.

National Rise In Patients Seeking Headache Relief

TruDenta, the creator of a diagnostic and treatment system for chronic headaches and other jaw-related symptoms, has reported a nationwide rise in the number of patients seeking relief from chronic head pain, neck pain, TMJ (temporomandibular joint) disorder, jaw pain, tinnitus, and vertigo. Ft. Lauderdale, Florida (PRWEB) November 21, 2014 TruDenta, the creator of a diagnostic and treatment syst...

Funding round brings in $7.5M for molecular Dx startup

A round of Series A financing headed by Sherpa Ventures has pulled in $7.5 million for molecular diagnostics startup Cue.  -More- 


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks